In vitro studies have indicated that Ivermectin may possess antiviral properties against various RNA viruses, including SARS-CoV-2. A proposed mechanism is its ability to interfere with the interaction between viral proteins and the host cell’s nuclear transport proteins (importin-$alpha$/$beta$1), which is necessary for viral replication.